Uv Flu Technologies(OTC) UVFT

UV Flu Technologies, Inc. is a company based in Lincolnshire, Illinois, specializing in the research, development, production, and distribution of advanced air purification systems. The company primarily serves the U.S. market with innovative products designed to capture and eliminate hazardous microbes.

Products and Services

• ViraTech UV-400, an advanced air purification system
• RX Air product line featuring HEPA technology air purifiers
• Solutions for diverse environments including hospitals and casinos

Growth Outlook

• Increasing demand for air purification solutions amid health concerns
• Expansion opportunities in various sectors, including healthcare and hospitality
• Potential for product innovation to enhance market competitiveness

Financial Highlights

• Recent quarterly revenue of $52,976, showing market interest
• Trailing twelve months (TTM) revenue of $166,000, indicating growth potential
• Current ratio of 0.16, reflecting liquidity challenges

UV Flu Technologies, Inc. operates in the industrial pollution and treatment controls sector, focusing on innovative air purification technologies. The flagship product, ViraTech UV-400, utilizes intense germicidal ultraviolet radiation to effectively eliminate harmful microbes, setting it apart from traditional filtration systems. The RX Air product line complements this offering with HEPA technology, catering to a wide range of environments, including healthcare facilities and hospitality venues. The growth outlook for UV Flu Technologies is promising, driven by an increasing awareness of air quality and health safety. The company is well-positioned to capitalize on the rising demand for effective air purification solutions, particularly in light of recent global health challenges. Opportunities for expansion into various sectors, including healthcare and hospitality, further enhance the company's growth potential. Financially, the company reported a recent quarterly revenue of $52,976, reflecting a growing interest in its products. The trailing twelve months (TTM) revenue of $166,000 indicates a potential upward trend, although the current ratio of 0.16 suggests liquidity challenges that may need to be addressed. Overall, UV Flu Technologies, Inc. presents an intriguing opportunity for investors interested in the air purification market, with a focus on innovative solutions and growth potential.